CSL SEQIRUS

HQ - Maidenhead

Summary

CSL Seqirus is a vaccine within the CSL biotechnology company, focused on preventing influenza and other infectious diseases, and is a major provider of influenza vaccines worldwide.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 6.25 B

Avg. Deal Size£ 6.25 B

Market Context